YuZheng Wu - Bioteque Head Department
| 4107 Stock | TWD 119.50 0.50 0.42% |
Insider
YuZheng Wu is Head Department of Bioteque
| Phone | 886 2 2571 0269 |
| Web | https://www.bioteq.com.tw |
Bioteque Management Efficiency
The company has return on total asset (ROA) of 0.0917 % which means that it generated a profit of $0.0917 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.182 %, meaning that it generated $0.182 on every $100 dollars invested by stockholders. Bioteque's management efficiency ratios could be used to measure how well Bioteque manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| WeiYing Yin | TTY Biopharm Co | N/A | |
| Fang Ho | United Orthopedic | N/A | |
| YanShen Lin | United Orthopedic | N/A | |
| Tim Chiang | Pacific Hospital Supply | N/A | |
| YungMin Chiang | TTY Biopharm Co | N/A | |
| ChengHsiao Chou | Excelsior Medical Co | N/A | |
| Yu Chou | StShine Optical Co | N/A | |
| WanCheng Yang | StShine Optical Co | N/A | |
| MingCheng Chang | Excelsior Medical Co | N/A | |
| JenYang Chang | TTY Biopharm Co | N/A | |
| SiYuan Yang | TTY Biopharm Co | N/A | |
| YuShiu Huang | Pacific Hospital Supply | N/A | |
| YuHsin Peng | United Orthopedic | N/A | |
| YuanChang Deng | United Orthopedic | N/A | |
| Eris Lin | StShine Optical Co | N/A | |
| YuYu Chou | StShine Optical Co | N/A | |
| Allen Chu | TTY Biopharm Co | N/A | |
| KuoChiang Chang | TTY Biopharm Co | N/A | |
| ChingLan Hou | TTY Biopharm Co | N/A | |
| AnTing Chung | Pacific Hospital Supply | N/A | |
| ShuWen Wang | TTY Biopharm Co | N/A | |
Management Performance
| Return On Equity | 0.18 | |||
| Return On Asset | 0.0917 |
Bioteque Leadership Team
Elected by the shareholders, the Bioteque's board of directors comprises two types of representatives: Bioteque inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bioteque. The board's role is to monitor Bioteque's management team and ensure that shareholders' interests are well served. Bioteque's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bioteque's outside directors are responsible for providing unbiased perspectives on the board's policies.
| JiaCheng Wu, Marketing Mang | ||
| Yizhong Huang, Head of Finance and Accounting | ||
| Yixun Li, Deputy General Manager, Director | ||
| PeiZhi Zhong, Head Accounting | ||
| Jinlong Lin, Deputy General Manager, Director | ||
| YuZheng Wu, Head Department |
Bioteque Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Bioteque a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.18 | |||
| Return On Asset | 0.0917 | |||
| Profit Margin | 0.26 % | |||
| Operating Margin | 0.30 % | |||
| Current Valuation | 7.75 B | |||
| Shares Outstanding | 69.3 M | |||
| Shares Owned By Insiders | 31.09 % | |||
| Shares Owned By Institutions | 26.66 % | |||
| Price To Book | 2.71 X | |||
| Price To Sales | 4.13 X |
Pair Trading with Bioteque
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bioteque position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bioteque will appreciate offsetting losses from the drop in the long position's value.Moving together with Bioteque Stock
Moving against Bioteque Stock
| 0.82 | 2454 | MediaTek | PairCorr |
| 0.75 | 3041 | ALi Corp Split | PairCorr |
| 0.72 | 2330 | Taiwan Semiconductor | PairCorr |
| 0.7 | 2308 | Delta Electronics | PairCorr |
| 0.65 | 5269 | Asmedia Technology | PairCorr |
The ability to find closely correlated positions to Bioteque could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bioteque when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bioteque - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bioteque to buy it.
The correlation of Bioteque is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bioteque moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bioteque moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bioteque can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Bioteque Stock Analysis
When running Bioteque's price analysis, check to measure Bioteque's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioteque is operating at the current time. Most of Bioteque's value examination focuses on studying past and present price action to predict the probability of Bioteque's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioteque's price. Additionally, you may evaluate how the addition of Bioteque to your portfolios can decrease your overall portfolio volatility.